WELLS FARGO & COMPANY/MN - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30,587
-59.9%
21,241
-30.7%
0.00%
Q2 2023$76,276
+2.2%
30,633
+10.0%
0.00%
Q1 2023$74,608
-46.1%
27,839
+9.2%
0.00%
Q4 2022$138,421
-79.6%
25,492
-53.1%
0.00%
Q3 2022$680,000
+333.1%
54,361
+71.2%
0.00%
Q2 2022$157,000
-54.2%
31,755
-29.6%
0.00%
Q1 2022$343,000
-41.6%
45,138
-21.5%
0.00%
Q4 2021$587,000
-58.9%
57,487
-46.0%
0.00%
Q3 2021$1,428,000
-32.8%
106,405
+9.9%
0.00%
Q2 2021$2,124,000
+12.1%
96,799
+23.0%
0.00%
Q1 2021$1,894,000
+149.9%
78,697
+86.7%
0.00%
Q4 2020$758,000
+117.2%
42,153
+39.6%
0.00%
Q3 2020$349,000
-48.0%
30,201
+9.2%
0.00%
Q2 2020$671,000
+210.6%
27,647
+41.3%
0.00%
Q1 2020$216,000
-57.0%
19,566
+2.9%
0.00%
Q4 2019$502,000
+10.3%
19,017
-4.8%
0.00%
Q3 2019$455,000
+8.9%
19,973
+46.5%
0.00%
Q2 2019$418,000
+66.5%
13,636
-9.8%
0.00%
Q1 2019$251,000
-13.4%
15,125
-0.1%
0.00%
Q4 2018$290,000
-46.2%
15,136
+46.8%
0.00%
Q3 2018$539,000
+28.6%
10,309
+7.0%
0.00%
Q2 2018$419,000
+103.4%
9,634
+73.5%
0.00%
Q1 2018$206,000
+123.9%
5,554
+19.3%
0.00%
Q4 2017$92,000
+557.1%
4,655
+749.5%
0.00%
Q3 2017$14,0005480.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders